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cohort studies
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neurologist,2 Steff Lewis,medical statistician,3Martin Dennis, professor,3 Peter Sandercock, professor,3 on
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Stroke Register
ABSTRACT
Objective To estimate the impact on long term survival of
functional status at six months after ischaemic stroke.
Design Prospective cohort study.
Settings Three cohorts: Oxfordshire community stroke
project, Lothian stroke register, and the first international
stroke trial (in the United Kingdom).
Participants 7710 patients with ischaemic stroke
registered between 1981 and 2000 and followed up for a
maximum of 19 years.
Main outcome measures Functional status at six months
after stroke assessed with modified Rankin scale or “two
simple questions.”Mortality during follow-up. Survival
analysiswithKaplan-Meier curves, log rank test, andCox’s
regression model.
Results In a combinedanalysis of all three cohorts, among
patients who survived to assessment six months after the
index stroke, the subsequent median length of survival
among those independent in daily living and those
dependent was 9.7 years (95% confidence interval 8.9 to
10.6) and 6.0 years (5.7 to 6.4), respectively. In a
combined analysis of the Oxfordshire and Lothian
cohorts, subsequent median survival fell progressively
from 12.9 years (10.0 to 15.9) for patients with a Rankin
score of 0-1 at sixmonths after the stroke to 2.5 years (1.4
to 3.5) for patients with a Rankin score of 5. All previously
stated differences inmedian survival were significant (log
rank test P<0.001). The influenceof functional outcomeon
survival remained significant (P<0.05) in each cohort after
adjustment for relevant covariates (such as age, presence
of atrial fibrillation, visible infarct on computed
tomography, subtype of stroke) in a Cox’s regression
model.
Conclusion Functional status six months after an
ischaemic stroke is associated with long term survival.
Early interventions that reduce dependency at six months
might have positive effects on long term survival.
INTRODUCTION
The global burden of stroke is large, yet there are still
gaps in our knowledge.1 2 Although there are now
reliable estimates on outcome in the early months and
years after an ischaemic stroke, we knowmuch less on
long term survival and what influences it.3 This lack of
information is important for many reasons. If, for
example, functional status severalmonths after a stroke
has a major influence on long term survival, this will
affect clinical practice (including our communication
with patients), our estimates of the future global burden
and costs of stroke, and the planning of health care and
research.
We estimated the relative and absolute effects of the
level of functional status at six months on long term
survival in three large prospective cohorts of patients
with ischaemic stroke.
METHODS
We sought data from three cohorts of patients with an
ischaemic stroke recruited in theUnited Kingdom: the
Oxfordshire community stroke project, the Lothian
stroke register, and theUKpatients enrolled in the first
international stroke trial.
Initial data collection and clinical follow-up
Oxfordshire community stroke project—This project was a
community based incidence study of stroke and
transient ischaemic attacks.4 Patients were registered
from 1981 to 1986. Details on the study population,
clinical definitions, methods of assessment, and inves-
tigations have been described in detail elsewhere.4 A
study neurologist assessed all patients as soon as
possible after the onset of symptoms. Baseline char-
acteristics were recorded in a standardised form.
Trained study nurses followed up surviving patients
at one, six, and 12months from the date of stroke onset
and then annually for up to five years.Whenpossible, a
study physician assessed survivors at the end of clinical
follow-up.
Lothian stroke register—The registerwas established to
collect data on patients with suspected stroke, transient
ischaemic attacks, or retinal artery occlusion from
those attending outpatient clinics and admitted to one
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hospital in Edinburgh. The registration began in 1990
and continued to 2000. One of the study’s stroke
physicians examined the patient and collected baseline
data as soon as possible after symptom onset. Patients
were followed up at 6, 12, 24, and 36 months from the
date of symptom onset. Follow-up data were obtained
either by telephone interview, postal questionnaire, or
home or clinic visits.
First international stroke trial—This was a randomised
trial of aspirin, subcutaneous heparin, both, or neither,
started within 48 hours of onset of ischaemic stroke.5 A
total of 19 435 patients were enrolled from 1991 to
1997, of whom 6257 (32%) were enrolled by hospitals
in the UK. Baseline data were collected before
randomisation in the trial. Final clinical follow-up at
six months was by postal questionnaire or telephone
interview or, in a few cases, during a clinic visit.
Collection of long term survival data
At the end of planned clinical follow-up in each of the
three cohorts, notes of patientswhowere still alivewere
“flagged” at the NHS central register of the Office for
National Statistics (ONS). On the death of a cohort
participant, ONS forwarded notification of the death
and a copy of the death certificate to the study office.
Patients whowere not reported to have died before the
closeof follow-upon16November2000wereassumed
to be alive.
Classification of ischaemic strokes
In all three cohorts, ischaemic stroke was diagnosed
with a combination of clinical criteria and brain
imaging or autopsy. As these examinations excluded
intracerebral haemorrhages and conditionsmimicking
stroke (for example, subdural haematoma or cerebral
tumour), the presence of visible infarction on imaging
(or autopsy) was not necessary for the diagnosis of
ischaemic stroke. According to criteria from the
Oxfordshire community stroke project classification,
we used the clinical features to subdivide diagnosis into
total anterior circulation infarct, partial anterior
circulation infarct, lacunar infarct, posterior circulation
infarct, or, when no clinical subtype could be assigned,
cerebral infarct of indeterminate clinical subtype.6
Definition of outcomes
In the Oxfordshire and Lothian cohorts the level of
function at six months after stroke onset was assessed
by the modified Rankin scale.7 In the international
stroke trial this was done by means of the “two simple
questions” that were developed to assess functional
outcome after stroke in large scale trials.8 The patients
(directly or through relatives) were asked if they had
needed help from another person to perform everyday
activities within the past two weeks (such as bathing,
feeding, walking, dressing, or use of the toilet). The
Rankin scoreand the two simplequestions aremethods
that both have good validity and reliability between
observers and correspondwell with each other.7 9 10We
definedan independent state asRankin scoreof 0-2 and
a dependent state as score of 3-5. The international
stroke trial classifiedpatientswho reportednot needing
any help to perform everyday activities within the past
two weeks as independent.
Statistical analysis
We estimated survival curves in the three cohorts with
the Kaplan-Meier product limit technique. We used
median rather than mean to describe and compare
survival from the six month assessment of functional
outcome in each cohort asmeans are hugely influenced
by the length of follow-up (which varied in the three
cohorts). We performed univariate and multivariate
analyses of risk factors with Cox’s proportional
hazards models. Data from patients who were dead at
six months after stroke onset were not entered in the
models as we were interested only in the impact of
functional status at six months on subsequent survival.
We entered age and systolic blood pressure as
continuous variables. The proportionality assumption
was verified with the Schoenfeld test and did not seem
to be violated.11 We used SPSS software (version 13.0
for Mac OS X) for the statistical analysis.
RESULTS
Oxfordshire cohort
This study registered 675patientswith first ever stroke.
We excluded 136 (20%). Of these, 130 did not have a
diagnosis of ischaemic stroke (33 had a subarachnoid
haemorrhage, 65 a primary intracerebral haemor-
rhage, and 32 a stroke of undefined pathological type).
We excluded six other patients in whom there was an
apparent error in the recordingof thedateof death.The
539 remaining patients had a definite (n=434) or
probable (n=105) ischaemic stroke.
Table 1 shows the baseline characteristics and vital
and dependency status at six months. Patients were
followedup for amaximumof 19 years. Figure 1 shows
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Fig 1 Oxfordshire cohort. Long term survival of patients in each
category of functional status (Rankin score 0-5) from
assessment at six months after index stroke
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survival curves forpatients stratifiedbyRankin score0-
5 at six months. There was a significant trend (log rank
test, P<0.001) of decreasing survival with increasing
Rankin score at six months. We entered all baseline
variables in table 1 and functional status at six months
after stroke onset into a univariate and multivariate
Cox’s regression model (table 2). Both the separate
Rankin scores and level of dependency at six months
had a significant effect (P<0.05) on subsequent survival
in the multivariate analyses. The more dependent a
patient was at six months, the shorter their subsequent
survival. Age and the presence of atrial fibrillation on
examination also had a significant negative effect
(P<0.001) on survival. We used a similar model to
analyse the impact of the Rankin scores at one month
after stroke onset. This gave generally the same results
as those of the Rankin scores at six months (data not
shown).
Lothian cohort
In all, 4455 patients with a stroke, transient ischaemic
attack, retinal artery occlusion, or other diagnosis were
entered on the register in 1990-9. We sought patients
with relevant clinical features and computed tomogra-
phy or magnetic resonance imaging at baseline
indicating an ischaemic infarct (n=1547) or patients
with normal results on computed tomography or
magnetic resonance imaging at baseline and a clinical
diagnosis of a probable (n=320) or definite stroke
(n=629).We excluded 442 (18%) of these patients from
our final analysis; 414 patients whose first follow-up
occurred (for organisational reasons) at 12 months or
later (hence functional status at six months was not
known), seven patients who were lost to follow-up by
sixmonths, one patient inwhom therewas an apparent
error in the recordingof the date of strokeonset, and20
patients who had refused further participation in the
study at some point after entry. In our final analyses we
therefore had data on 2054 patients.
Table 1 shows baseline characteristics and vital and
dependency status at six months. Patients were
followed up for a maximum of 9.7 years. Figure 2
shows survival curves. There was a significant trend
(log rank test, P<0.001) of a decrease in survivalwith an
increase in Rankin score at sixmonths.We entered the
baseline variables in table 1 and the functional status at
six months after stroke onset in a univariate and
multivariateCox’s regressionmodel (table 3). Both the
separate Rankin scores and the level of dependency
had a significant effect (P<0.001) on survival in
multivariate analyses. Age, sex, and the presence of
atrial fibrillation also had significant negative effects
(P<0.05) on survival.
International stroke trial cohort
Aprobable or definite ischaemic stroke was diagnosed
in 5139 patients recruited in the UK. We excluded 22
(0.4%) patients from the final analysis as we did not
know their dependency status at six months (n=20) or
there was an error in the recording of the date of death
(n=2). Table 1 shows the baseline characteristics.
Among the patients with probable or definite ischae-
mic stroke, 49% underwent computed tomography
before randomisation into the trial; in the remainder
the diagnosis was confirmed either by computed
tomography after randomisation or by autopsy. Figure
3 shows the survival curves for patients who were
Table 1 | Baseline characteristics and status of patients at sixmonths after stroke onset in three
cohorts. Figures are numbers (percentages) of patients unless stated otherwise
OCSP (n=539) LSR (n=2054) IST-1 (n=5117)
All cohorts
(n=7710)
Mean (SD) age (years) 73 (12) 68 (13) 73 (11) 72 (12)
Men 269 (50) 1087 (53) 2683 (52) 4039 (52)
Mean (SD) systolic BP (mm Hg) 162 (33) 157 (30) 158 (27) 158 (28)
Atrial fibrillation onbaseline ECG 84 (16)* 259 (13)† 1012 (20)‡ 1355 (18)
CT performed at baseline 472 (88) 2054 (100) 2499 (49)§ 5025 (65)
Visible infarct on baseline CT 263 (56) 1245 (61) 1639 (66)§ 3147 (63)
Medication before stroke:
Antiplatelet 17 (4) 641 (31) 1281 (25)¶ 1939 (25)
Anticoagulant 6 (1) 84 (4) 39 (1)** 129 (2)
Stroke syndrome:
TACI 92 (17) 246 (12) 1437 (28) 1775 (23)
PACI 182 (34) 811 (39) 2072 (40) 3065 (40)
LACI 137 (25) 546 (27) 1042 (20) 1725 (22)
POCI 128 (24) 342 (17) 551 (11) 1021 (13)
Indeterminate subtype — 109 (5) 15 (0.3) 124 (2)
Status at six months:
Independent 285 (53) 1142 (56) 1098 (22) 2525 (33)
Dependent 154 (29) 604 (29) 2678 (52) 3436 (45)
Dead 100 (18) 308 (15) 1341 (26) 1749 (23)
OCSP=Oxfordshire community stroke project; LSR=Lothian stroke register; IST-1=first international stroke trial;
ECG=electrocardiogram; CT=computed tomography; TACI=total anterior circulation infarct; PACI=partial anterior
circulation infarct; LACI=lacunar infarct; POCI=posterior circulation infarct.
*Missing data in 11 patients.
†Not recorded in 288 patients.
‡Not recorded in 348 patients during pilot phase of trial.
§Diagnosis confirmed in remainder by CT after randomisation or by autopsy. “Visible infarct on CT” refers only to
those scans performed before randomisation.
¶Not recorded in 348 patients during pilot phase and subsequently recorded only if aspirin was used.
**Not recorded in 153 patients during pilot phase and use subsequently recorded only if heparin was used.
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Fig 2 Lothian cohort. Long term survival of patients in each
category of functional status (Rankin score 0-5) from
assessment at six months after index stroke
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independent and dependent at six months after
randomisation. There was a significant effect (log
rank test, P<0.001) of the level of dependency on
survival. We entered all baseline variables in table 1
and the functional status at sixmonths after strokeonset
in a Cox’s regression model (table 4). The level of
dependency at six months had a significant effect
(P<0.001) on survival in themultivariate analysis. Age,
sex, presence of atrial fibrillation on baseline examina-
tion, useof aspirinbefore the stroke, and stroke subtype
were also significant (P<0.05).
Pooled estimate of median survival
Table 5 shows estimates of the median survival time,
subdivided by Rankin score, based on the combined
dataset of the Lothian and Oxfordshire cohorts. There
was a significant trend (log rank test P<0.001) of
decreasing median survival with increasing Rankin
score. Table 5 also gives estimates of median survival
for independent and dependent patients based on data
from all three cohorts combined. This difference was
highly significant (log rank test, P<0.001).
Survival among cohorts recruited in different time
periods
We compared survival in all three cohorts among
independent and dependent patients who were
enrolled during three different time periods (1981-6,
1990-4, and1995-2000). Estimatedmedian survival for
patients whowere dependent at sixmonths after stroke
onsetwas4.2years among those recruitedduring1981-
6 and 6.5 years among those recruited during 1990-4.
No accurate estimations can be given for the period
1995-2000, as over half of both dependent and
independentpatientswere alive at the endof follow-up.
Wealso analysed the influenceof yearof recruitment
on two year survival in the Lothian and international
stroke trial cohorts. We compared the proportions of
patients who were alive at two years. Among patients
recruited in 1990-4 and 1995-2000 who were indepen-
dent at the six month assessment the proportions alive
at two years were 90% and 93%, respectively. Among
those recruited in the same years who were dependent
at the sixmonthassessment theproportions alive at two
years were 80% and 81%. These differences were not
significant.
We also entered the date of stroke onset (or date of
randomisation in the international stroke trial cohort)
as a variable in the multivariate Cox’s regression
analyses of each cohort. Date of stroke onset was not a
significant variable in the Oxfordshire (P=0.45) and
Lothian (P=0.083) cohorts. The date of randomisation
was a significant variable (P<0.001) in the international
stroke trial cohort. A multivariate Cox’s regression
analysis in the international stroke trial cohort showed
that, among patients recruited in 1995-7, survival was
significantly greater than among those recruited in
1991-4 (P<0.001; hazard ratio 0.82, 95% confidence
interval 0.73 to 0.91).
DISCUSSION
This study provides robust estimates of the relative and
absolute effects that the level of dependency sixmonths
after an ischaemic stroke has on subsequent long term
survival. The impact of functional status on median
survival was substantial and remained significant after
adjustment for baseline variables known to influence
prognosis. The findings were consistent in size and
direction across these three, somewhat different,
cohorts of ischaemic stroke patients.
Wewere surprised to see thepoor survival ofpatients
with a Rankin score of 4-5. The five year survival for
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Fig 3 International stroke trial cohort. Long term survival of
patients who were alive and dependent or independent from
assessment at six months after randomisation
Table 2 | Univariate andmultivariate Cox’s regression analyses of baseline variables for patients
aliveatsixmonthsafterstrokeonsetinOxfordshirecommunitystrokeproject. Figuresarehazard
ratios (95%confidence intervals)
Variable Univariate analysis Multivariate analysis
Age 1.05 (1.04 to 1.07)*** 1.04 (1.03 to 1.06)***
Male sex 0.99 (0.80 to 1.24) 1.22 (0.98 to 1.54)
Mean systolic BP 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Atrial fibrillation 1.94 (1.43 to 2.65)*** 1.85 (1.33 to 2.58)***
Visible infarct on CT 1.19 (0.96 to 1.49) 1.13 (0.89 to 1.43)
Antiplatelet use before stroke 1.08 (0.60 to 1.92) 0.95 (0.52 to 1.73)
Anticoagulant use before stroke 0.62 (0.20 to 1.93) 0.64 (0.19 to 2.14)
Stroke syndrome:
LACI 1 1
PACI 1.05 (0.80 to 1.38) 0.93 (0.70 to 1.24)
POCI 1.12 (0.84 to 1.51) 1.14 (0.84 to 1.55)
TACI 1.29 (0.84 to 1.97) 0.90 (0.56 to 1.45)
Rankin score (at six months)†
0 1 1
1 1.25 (0.72 to 2.17) 1.20 (0.69 to 2.08)
2 2.06 (1.19 to 3.55)* 1.54 (0.90 to 2.67)
3 2.69 (1.53 to 4.75)*** 2.04 (1.15 to 3.63)*
4 2.78 (1.57 to 4.93)*** 1.82 (1.02 to 3.26)*
5 2.12 (0.93 to 4.83) 1.25 (0.54 to 2.90)
Functionally dependent 1.76 (1.40 to 2.20)*** 1.38 (1.09 to 1.75)***‡
CT=computed tomography; LACI=lacunar infarct; PACI=partial anterior circulation infarct; POCI=posterior
circulation infarct; TACI=total anterior circulation infarct.
*P<0.05 ***P<0.001
†Overall P values of Rankin score (at six months): univariate analysis P<0.001 and multivariate analysis P=0.009
‡Separate multivariate analysis without entering the variable “Rankin score (at six months).”
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this groupwasabout45%,which isworse than formany
malignancies. Not surprisingly, median survival was
negatively influenced by age at onset of stroke in all
cohorts. The presence of atrial fibrillation on the first
examination also significantly influenced long term
survival in the three cohorts, as shown in previous
studies.12 13
Strengths and weaknesses
The strength of these data rests on the fact that the
cohorts were large and well characterised, the baseline
data were generally complete, and follow-up was
prospective and prolonged, with minimal loss to six
month and prolonged follow-up. The scope for
selection bias in the assembly of these cohorts was
least for the community basedOxfordshire cohort and
greatest for the randomised international stroke trial.
We did not include 414 patients with ischaemic stroke
from the Lothian study because data were collected at
one year (instead of six months), but an analysis that
included these 414 patients showed no significant
differences in overall survival. Hence, the exclusion of
these patients did not have a substantial influence on
our findings in this cohort. Our analyses are based on
the assumption that patients not reported as dead were
alive and that official statistics are accurate. Patients
whomoved abroad after inclusion in one of the cohorts
and died while overseasmight not have been recorded
if the death certificate was not sent to the UK. We also
cannot exclude the further possibility that independent
survivors might have been more likely, and able, to
emigrate than dependent ones. These effects might
have led to an overestimation of median survival in all
cohorts, though we think the effect would be small
because emigration, especially among elderly people,
is relatively uncommon.14 15
Relevance of findings
The consistency across the three cohorts of the effect of
the patient’s level of dependency on subsequent
survival suggests that the relative effects are
Table 4 | Univariate andmultivariate Cox regression analyses of baseline variables for patients
alive at sixmonthsafter randomisation into the first international stroke trial. Figuresarehazard
ratios (95%confidence intervals)
Variable Univariate analysis Multivariate analysis
Age 1.07 (1.06 to 1.07)*** 1.07 (1.06 to 1.07)***
Male sex 0.97 (0.88 to 1.07) 1.42 (1.28 to 1.58)***
Mean systolic BP 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Atrial fibrillation 1.64 (1.45 to 1.86)*** 1.16 (1.02 to 1.32)*
Visible infarct on CT 0.95 (0.85 to 1.06) 1.05 (0.94 to 1.17)
Antiplatelet use before stroke 1.21 (1.08 to 1.35)* 1.17 (1.04 to 1.31)*
Anticoagulant use before stroke 0.71 (0.35 to 1.42) 0.62 (0.31 to 1.24)
Stroke syndrome†:
LACI 1 1
PACI 1.25 (1.09 to 1.42)* 1.15 (1.01 to 1.31)*
POCI 0.98 (0.81 to 1.19) 1.04 (0.86 to 1.26)
TACI 1.44 (1.24 to 1.66)*** 1.23 (1.06 to 1.43)*
Indeterminate subtype 0.28 (0.07 to 1.14) 0.36 (0.09 to 1.43)
Functionally dependent (at six
months)
1.91 (1.68 to 2.16)*** 1.63 (1.43 to 1.85)***
CT=computed tomography; LACI=lacunar infarct; PACI=partial anterior circulation infarct; POCI=posterior
circulation infarct; TACI=total anterior circulation infarct.
*P<0.05, ***P<0.001.
†Overall P values of stroke syndrome: univariate analysis P<0.01 and multivariate analysis P=0.03.
Table 5 | Combined analysis estimating effect of functional
status at sixmonths on subsequentmedian survival
Functional status Median survival (years) (95% CI)
Rankin score in Oxfordshire and Lothian cohorts (No of patients):
0 (311) >15*
1 (540) 11.7 (8.4 to 14.9)
2 (576) 8.4 (7.6 to 9.3)
3 (433) 6.0 (5.2 to 6.8)
4 (189) 3.7 (2.9 to 4.6)
5 (136) 2.5 (1.4 to 3.5)
All three cohorts (No of patients):
Independent (2525) 9.7 (8.9 to 10.6)
Dependent (3436) 6.0 (5.7 to 6.4)
*Exact median not given as less than half of patients died during follow-
up. Median survival 12.9 years (95% CI 10.0 to 15.9) for Rankin 0 and 1
combined.
Table 3 | Univariate andmultivariate Cox’s regression analyses of baseline variables for patients
alive at sixmonths after stroke onset in Lothian stroke register. Figures are hazard ratios (95%
confidence intervals)
Variable Univariate analysis Multivariate analysis
Age 1.06 (1.05 to 1.07)*** 1.05 (1.04 to 1.06)***
Male sex 1.05 (0.87 to 1.26) 1.33 (1.08 to 1.64)*
Mean systolic BP 1.00 (0.99 to 1.01) 1.00 (1.00 to 1.00)
Atrial fibrillation 3.00 (2.37 to 3.80)*** 1.65 (1.25 to 2.17)*
Visible infarct on CT 1.22 (1.01 to 1.47)* 1.09 (0.89 to 1.35)
Antiplatelet use before stroke 1.48 (1.22 to 1.80)*** 1.31 (1.07 to 1.62)*
Anticoagulant use before stroke 1.07 (0.63 to 1.82) 0.91 (0.51 to 1.60)
Stroke syndrome†:
LACI 1 1
PACI 1.57 (1.24 to 2.00)*** 1.32 (1.02 to 1.72)*
POCI 1.01 (0.74 to 1.39) 1.16 (0.83 to 1.62)
TACI 2.25 (1.63 to 3.11)*** 1.22 (0.83 to 1.79)
Indeterminate subtype 1.25 (0.77 to 2.04) 1.14 (0.68 to 1.92)
Rankin score (at six months)‡:
0 1 1
1 1.01 (0.66 to 1.56) 0.98 (0.63 to 1.54)
2 1.66 (1.12 to 2.46)* 1.74 (1.16 to 2.61)*
3 2.86 (1.95 to 4.20)*** 2.58 (1.73 to 3.87)***
4 4.11 (2.69 to 6.30)*** 3.89 (2.48 to 6.12)***
5 6.41 (4.23 to 9.73)*** 4.98 (3.15 to 7.88)***
Functionally dependent 2.87 (2.38 to 3.46)*** 2.43 (1.96 to 3.01)***§
CT=computed tomography; LACI=lacunar infarct; PACI=partial anterior circulation infarct; POCI=posterior
circulation infarct; TACI=total anterior circulation infarct.
*P<0.05, ***P<0.001
†Overall P values of stroke syndrome: univariate analysis P<0.001 and multivariate analysis P=0.32.
‡Overall P values of Rankin score (at six months): univariate and multivariate analysis P<0.001.
§Separate multivariate analysis without variable “Rankin score (at six months).”
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generalisable. A graded effect was evident in the three
cohorts, even though therewere variations in casemix,
time period, and location. Also, the demographics of
the three studies suggest that the results are generali-
sable. The mean age of patients in the three cohorts
(ranging from68 to 73 years)was similar to that in large
community and hospital based studies of ischaemic
stroke patients.16-22 The proportions of stroke subtypes
according to the Oxfordshire community stroke
project classification in our cohorts were similar to
those found in other studies (though there were fewer
total anterior circulation infarcts in the Lothian and
Oxfordshire cohorts), as were the outcomes in terms of
early case fatality and the proportion of patients who
were dead or dependent at six months.16-25 These
cohorts, however, were assembled at a time when
secondary prevention in stroke survivors was much
less intensive thannow.Ouranalysesof survival during
different time periods showed, as one might expect,
that survival did indeed slightly improve over time.
Hence, when we apply these estimates to current
patients, it may be reasonable to assume that on
average, at a given level of dependency, median
survival would be somewhat better than portrayed
here.26
We believe that these data have several implications
for clinical practice. They can be used to inform
patients and their relatives about the prognosis after an
ischaemic stroke. They have implications for the
estimation of the impact and costs of stroke and for
the planning of health care and research. Estimates of
global disease burden and costs have so far relied
mainly on modelling techniques. Our data could be
used to assess the cost effectivenessof treatments for the
acute phase of stroke. Previous studies have shown that
the costs of long term care account for about half of the
total costs of stroke care.27-29Ahealth economicsmodel
has suggested that treatments that reduce dependency
in survivors by only a modest amount might, none the
less, have a substantial effect on long term survival free
of dependency and hence prove highly cost
effective.30 31Ourdata strongly support this hypothesis.
Future studies should assess whether early
interventions that reduce functional dependency at
sixmonths after onset of ischaemic strokehavepositive
effects on subsequent long term survival, as our study
suggests.
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